GMI-1757

N/A

Report date: 2025/06/19 16:46:51
NME

Base Information

Drug NameGMI-1757
Drug Alias NameGMI-1757
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGalectin-3 inhibitorsSelectin E inhibitors
TargetsSelectin EGalectin-3
Therapy Area/IndicationsFibrosisThrombosisPancreatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCrescent Biopharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesCrescent Biopharma Inc
Inactive CompaniesN/A
Active IndicationsThrombosis
Inactive IndicationsFibrosisPancreatic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A